Skip to content

Clinical trials

Neurocognitive Disorders trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Country / region: France Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20174
20182
20194
20202
20212
20228
20237
20242
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting12
Unknown status5
Terminated4
Not yet recruiting4
Active, not recruiting3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Hospitalier Universitaire de Nice6
Hospices Civils de Lyon6
University Hospital, Angers3
AstraZeneca2
Central Hospital, Nancy, France2
MapLight Therapeutics2
RIVAGES2
ANRS, Emerging Infectious Diseases1
Alkahest, Inc.1
AskBio France, SAS, a subsidiary of AskBio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders42
Alzheimer Disease16
Dementia15
Brain Diseases11
Neurodegenerative Diseases10
Central Nervous System Diseases9
Mental Disorders9
Nervous System Diseases9
Tauopathies7
Cognitive Dysfunction5

Trials

Showing 51 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.